Please check your internet connection and try again.
# Ezivac enema
## Overview
Ezivac enema is a hyperosmotic laxative containing sodium phosphate and sodium lauryl sulfate. It works by drawing water into the colon, softening stool and stimulating bowel movements.
## Primary Indications
Constipation.
## Adult Dosing
A single enema (typically 118 mL) is administered rectally as needed. Do not exceed one enema in a 24-hour period.
## Pediatric Dosing
**Ages 2 years and older:** Follow adult dosing under medical supervision.
**Under 2 years:** Contraindicated.
## Dose Adjustments
No dose adjustments are typically needed for renal or hepatic impairment, but caution is advised due to the risk of electrolyte disturbances.
## Contraindications
* Congenital or acquired megacolon
* Intestinal obstruction or perforation
* Appendicitis or undiagnosed abdominal pain
* Children under 2 years of age
* Patients with impaired renal function (caution advised)
* Patients with heart failure or other conditions requiring sodium restriction (caution advised)
## Adverse Effects
* Abdominal cramping, pain, bloating
* Nausea, vomiting
* Diarrhea
* Electrolyte disturbances (hyperphosphatemia, hypocalcemia, hypernatremia, hypokalemia), particularly with overuse or in patients with renal impairment. This can lead to severe complications like cardiac arrhythmias, seizures, and kidney damage.
* Rectal irritation or bleeding.
## Key Drug Interactions
* **Diuretics, ACE inhibitors, ARBs, NSAIDs:** Increased risk of hyperphosphatemia and renal impairment.
* **Calcium or magnesium-containing antacids:** Increased risk of hyperphosphatemia.
* **Medications affected by electrolyte shifts:** Concomitant use with drugs that affect electrolytes (e.g., potassium-sparing diuretics) may exacerbate electrolyte imbalances.
## Monitoring
* Monitor for signs and symptoms of electrolyte imbalance, especially in patients with predisposing conditions or those who use the product frequently.
* Assess for adequate hydration.
## Clinical Pearls
* Administer slowly and retain for the duration recommended on the product labeling (usually 2-5 minutes) to ensure efficacy.
* Avoid if stooling has not occurred for more than 3 days or if experiencing severe abdominal pain, nausea, or vomiting.
* Excessive or frequent use can lead to serious electrolyte abnormalities and dependence.
* Limited data exists on repeated use in children; use with extreme caution and under medical guidance.
---
***Disclaimer:** This information is intended for clinical pharmacists and healthcare professionals. It is essential to consult the most current prescribing information and relevant clinical guidelines for complete and up-to-date guidance before making any treatment decisions. Drug information can change rapidly.*
